Single company EIS

Single company EIS deals are private offers for experienced investors. 

They give you an opportunity to invest directly in a particular company you consider commercially compelling and able to deliver attractive returns, with the benefit of EIS tax relief. Please remember, tax rules can change and benefits depend on circumstances.

So, unlike with EIS funds where the asset manager makes the investment decisions on your behalf, you are in control, you decide which company to back. Get it right, and the reward could be considerable. 

But one cannot expect to get it right each time. You are investing in early-stage companies – inevitably some will fail. To help mitigate this, it might be wise to diversify and spread your EIS investments each year over a number of single companies.

How could you access single company deals? 

Thousands of EIS-qualifying companies raise funds. The latest figures show 3,905 businesses raised over £1.8 billion under EIS in just one year (2018/19). 

We aim to offer a selection of quality EIS opportunities you often wouldn't be able to get elsewhere. Each has been carefully assessed, either by Wealth Club or by reputable and established counterparties. To help you make your own informed decisions, we provide you with insight and comment on each offer. This is free to Wealth Club members. 

  • Our choice

    Acamar Films EIS (Bing)

    This is a rare opportunity to help an internationally successful character become a potentially multi-£billion global icon. Acamar Films Ltd is the independent production company behind Bing, the most successful programme in BBC CBeebies’ digital history.

    Read more about Acamar Films EIS (Bing)
    Type
    Single company
    Sector
    Media
    Target return
    3x
    Funds raised / sought
    £1.1 million / £1.5 million
    Minimum investment
    £20,482
    Deadline
    30 Apr 2021 for 2021/22 allotment
  • Our choice

    Salus Optima EIS

    Co-invest with the multi-£billion company behind one of the most successful teams in Formula 1: data-driven digital health platform with five major multi-year SaaS and distribution contracts with global corporations (including a US Fortune 100 company). Salus Optima has developed a digital platform that uses artificial intelligence (AI) to give people personalised health guidance. Read more and download research report...

    Read more about Salus Optima EIS
    Type
    Single company
    Sector
    Healthcare & Technology
    Target return
    10x (59% IRR)
    Funds raised / sought
    £1.0 million sought
    Minimum investment
    £18,795
    Deadline
    30 Apr 2021 for first allotment